1-3 of 3
Stefan Tiefenbacher
Close
Sort by
Journal Articles

Activity of transgene-produced B-domain–deleted factor VIII in human plasma following AAV5 gene therapy

Steffen Rosen, Stefan Tiefenbacher, Mary Robinson, Mei Huang, Jaydeep Srimani, Donnie Mackenzie, Terri Christianson, K. John Pasi, Savita Rangarajan, Emily Symington, Adam Giermasz, Glenn F. Pierce, Benjamin Kim, Stephen J. Zoog, Christian Vettermann
Journal: Blood
Blood (2020) 136 (22): 2524–2534.
https://doi.org/10.1182/blood.2020005683
Published: 2020
Includes: Supplemental data
Journal Articles

Assay Interference By Emicizumab in Aptt and Chromogenic Based FVIII:C and Inhibitor Assays

Brian F Poirier, MD, Mary Robinson, PhD, Stefan Tiefenbacher, PhD, Erin McEwan, Caroline Cogswell, Roxy Gode, Emily Burger, Tyler Allison, Jennifer Littlefield, Amanda Pikas, Andrea Schmoker
Journal: Blood
Blood (2020) 136 (Supplement 1): 20.
https://doi.org/10.1182/blood-2020-142132
Published: 2020
Journal Articles

Activity of a FIX-Padua Transgene Product in Commonly Used FIX:C One-Stage and Chromogenic Assay Systems Following PF-06838435 (SPK-9001) Gene Delivery

Mary Robinson, PhD, Lindsey A. George, MD, Benjamin J. Samelson-Jones, MD PhD, Valder R Arruda, MD PhD, Katherine A. High, MD, Marcus E Carr, MD PhD, Stefan Tiefenbacher, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2198.
https://doi.org/10.1182/blood-2018-99-119616
Published: 2018